Brenda Pearson
University of North Carolina at Chapel Hill
ORCID: 0000-0002-4662-1748Also affiliated with Cornell University, Presbyterian Hospital
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 3 papers. Top paper: “Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis”.
Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis
Christopher S. Coffey, Jonathan M. Goldstein, Mazen M. Dimachkie, Michael Benatar, John T. Kissel +25 more
Leonard Abbeduto, Randi J. Hagerman, Christopher S. Coffey, Merit Cudkowicz, Craig A. Erickson +21 more
Cort A. Pedersen, Samantha Meltzer‐Brody, Brenda Pearson, Alison M. Stuebe, Karen Grewen